+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Over The Counter (OTC) Testing - Global Strategic Business Report

  • PDF Icon

    Report

  • 89 Pages
  • November 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5303623
The global market for Over The Counter (OTC) Testing was estimated at US$23.3 Billion in 2023 and is projected to reach US$43.6 Billion by 2030, growing at a CAGR of 9.3% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Over-the-Counter (OTC) Testing Market - Key Trends & Drivers Summarized

Why Is Over-the-Counter Testing Essential for Accessible Healthcare?

Over-the-counter (OTC) testing has revolutionized healthcare by providing individuals with direct access to health tests that can be conducted privately and conveniently at home. OTC tests enable users to monitor a range of health indicators, from blood glucose and cholesterol levels to pregnancy, fertility, and infectious diseases, without requiring a doctor's visit or prescription. As healthcare shifts toward more patient-centered and accessible care, OTC testing has become an essential tool for individuals seeking to manage their health proactively. By allowing people to test at their convenience, OTC tests eliminate barriers associated with traditional lab-based testing, such as time, cost, and accessibility issues, making healthcare more inclusive.

OTC testing has been particularly impactful for managing chronic conditions like diabetes, where continuous monitoring is crucial for effective care. Blood glucose meters, one of the most widely used OTC tests, empower diabetic patients to track their sugar levels daily, aiding in medication management and lifestyle adjustments. Similarly, at-home cholesterol tests allow individuals at risk of cardiovascular disease to monitor their health and make informed lifestyle changes. With an aging population and increasing rates of chronic illnesses, OTC testing provides a practical solution for regular health monitoring, supporting early detection and intervention. This accessibility not only improves individual health outcomes but also reduces the burden on healthcare facilities, as fewer resources are required for routine monitoring.

Additionally, OTC testing has gained traction in response to rising health awareness, as more people seek ways to take control of their wellness. From fertility tests for couples planning a family to genetic testing kits for understanding ancestry and predispositions, OTC testing meets the demand for personalized, preventive healthcare. With rapid advances in testing technology, a growing range of reliable, user-friendly OTC tests is now available, catering to diverse needs and empowering individuals to stay informed about their health. By making diagnostic testing accessible to the general public, OTC testing bridges the gap between individuals and timely healthcare, enabling early interventions and proactive health management.

How Are Technological Advancements Enhancing the OTC Testing Market?

Technological advancements have been instrumental in the growth and evolution of the OTC testing market, making tests more accurate, affordable, and user-friendly. Innovations in biochemical and molecular testing have significantly improved the sensitivity and specificity of OTC tests, providing users with reliable results that are comparable to lab-based testing. For example, advancements in lateral flow and immunoassay technologies have enhanced rapid testing for conditions like pregnancy, infectious diseases, and drug use. These tests now produce results within minutes, offering individuals fast, convenient health insights. Digital technology integration, such as Bluetooth-enabled blood glucose meters and smartphone apps, allows users to track, store, and analyze their health data, helping them make informed decisions and share results with healthcare providers as needed.

At-home genetic testing is another area that has benefited from technological advancements, making it possible to analyze DNA from a simple saliva sample. DNA testing kits, which were once expensive and only available through specialized labs, are now accessible through OTC channels and provide users with insights into their ancestry, health risks, and genetic predispositions. These kits use advanced genomic analysis algorithms and lab processing to interpret complex genetic data, presenting it in an accessible format for consumers. As people become more interested in personalized health information, OTC genetic testing offers an easy way to understand genetic health risks, which can guide lifestyle choices and preventive care. The rise of personalized healthcare has fueled demand for these tests, supporting further innovation in OTC testing technology.

Telemedicine and digital health platforms have also driven growth in the OTC testing market by creating an ecosystem that connects at-home testing with healthcare providers. Digital health apps, many of which are compatible with OTC testing devices, allow users to consult healthcare professionals remotely and receive guidance based on their test results. This integration of OTC testing with telemedicine provides a seamless experience, where users can test at home and consult a doctor online, all within a short timeframe. For example, COVID-19 home tests allow individuals to receive test results without leaving their home, reducing exposure and facilitating timely medical advice if needed. As telemedicine adoption expands, the synergy between at-home testing and virtual care strengthens the relevance of OTC tests, creating a holistic healthcare experience that prioritizes accessibility and convenience.

What Are the Benefits of OTC Testing for Consumers and Healthcare Providers?

OTC testing provides substantial benefits for both consumers and healthcare providers, making it a valuable tool in enhancing healthcare accessibility and efficiency. For consumers, the main advantage of OTC testing is convenience. By enabling people to test at home, OTC testing eliminates the need for scheduling, travel, and waiting times associated with traditional lab tests. This convenience is especially beneficial for individuals with mobility issues, those living in rural areas, or people with busy schedules who find it challenging to visit a healthcare facility. OTC tests, such as pregnancy tests, blood glucose meters, and rapid antigen tests, offer users immediate results and peace of mind. By reducing the dependency on lab visits, OTC testing empowers consumers to take control of their health and monitor their well-being at any time, supporting proactive health management.

For individuals with chronic conditions, OTC testing offers the critical benefit of continuous health monitoring. Regular at-home testing for blood glucose, cholesterol, or blood pressure enables individuals to manage their conditions more effectively, preventing complications and allowing for timely medical interventions. This continuous monitoring capability improves patient compliance, as users can conveniently track their progress without frequent clinic visits.

OTC tests also enhance health outcomes by promoting early detection of conditions like high cholesterol or abnormal glucose levels, allowing individuals to make lifestyle changes or seek medical advice before conditions worsen. For example, at-home colon cancer screening tests allow for early detection, significantly improving survival rates when treatment begins early. OTC testing thus plays a crucial role in preventive care, supporting individuals in making informed decisions about their health.

Healthcare providers also benefit from OTC testing, as it helps alleviate the demand on healthcare facilities and enables providers to focus on critical cases. By empowering patients to monitor their health independently, OTC testing reduces the number of routine lab visits, freeing up resources for patients who require more intensive care. This is particularly beneficial in managing the rising demand for healthcare services and minimizing bottlenecks in the healthcare system.

Additionally, data collected from OTC testing can be shared with healthcare providers, allowing for remote monitoring of patients with chronic conditions. Providers can use this data to track patient progress, make adjustments to treatment plans, and intervene promptly if issues arise. By facilitating efficient patient monitoring, OTC testing supports a collaborative approach to healthcare that enhances outcomes and reduces the burden on healthcare infrastructure.

What Is Fueling the Growth in the OTC Testing Market?

The growth in the OTC testing market is driven by factors such as rising health awareness, the need for accessible healthcare solutions, advancements in testing technology, and the increasing prevalence of chronic conditions. As health awareness continues to rise, more people are seeking tools that allow them to monitor their health from home, leading to a greater demand for OTC tests. Consumers today are more proactive in managing their health, and OTC testing offers a convenient way to check for conditions like high blood pressure, cholesterol, and glucose levels without the need for frequent doctor visits. This self-management approach aligns with the growing trend of preventive healthcare, where individuals monitor their health regularly to detect and address potential issues early.

The need for accessible healthcare solutions has also contributed significantly to the growth of the OTC testing market, as healthcare systems worldwide face challenges in meeting the demands of an aging population and managing limited resources. OTC testing provides a cost-effective solution by enabling individuals to take routine tests at home, reducing the burden on healthcare facilities and making testing accessible to a wider population. In rural or underserved areas where healthcare access is limited, OTC testing bridges the gap by providing essential diagnostic capabilities without requiring travel to a medical facility. As healthcare costs continue to rise, OTC testing offers an affordable alternative that supports broader access to healthcare, especially in regions with limited medical infrastructure.

Technological advancements in testing accuracy and ease of use have also accelerated the adoption of OTC testing. Innovations in biotechnology have improved the reliability and specificity of OTC tests, making them highly accurate and comparable to lab-based tests. For instance, advancements in rapid diagnostic tests have made it possible to detect infectious diseases like COVID-19 and influenza at home, providing users with timely information that can guide decisions on self-isolation and medical care. Additionally, the rise of telehealth has further integrated OTC testing into healthcare, as remote consultations and digital health platforms allow patients to receive medical advice based on their at-home test results. This seamless integration of OTC testing and telemedicine is especially appealing to patients seeking accessible and efficient healthcare solutions.

Finally, the increasing prevalence of chronic conditions, such as diabetes, cardiovascular disease, and high blood pressure, has fueled demand for OTC testing products that allow for regular monitoring. As chronic diseases require frequent health checks, OTC testing offers a convenient, effective solution for patients to monitor their condition consistently. Blood glucose monitors, cholesterol tests, and blood pressure cuffs are commonly used by individuals managing these chronic conditions, enabling them to adjust their treatment plans as needed.

This trend is likely to continue as chronic conditions remain a significant public health issue, with OTC testing providing patients with the tools to manage their health proactively. Together, these factors - rising health awareness, the need for accessible healthcare, technological advancements, and the prevalence of chronic conditions - are driving substantial growth in the OTC testing market, making it a cornerstone of modern healthcare and preventive medicine.

Scope of the Study

The report analyzes the Over The Counter (OTC) Testing market, presented in terms of market value (US$ Million). The analysis covers the key segments and geographic regions outlined below.

Segments

Test Type (Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests, Other Test Types); Technology (Lateral Flow Assays, Immunoassays, Dipsticks)

Geographic Regions/Countries

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Glucose Monitoring Tests segment, which is expected to reach US$11.7 Billion by 2030 with a CAGR of a 8.2%. The Pregnancy & Fertility Tests segment is also set to grow at 9.5% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $6.3 Billion in 2023, and China, forecasted to grow at an impressive 8.8% CAGR to reach $6.8 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Over The Counter (OTC) Testing Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Over The Counter (OTC) Testing Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Over The Counter (OTC) Testing Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players in the Global Over The Counter (OTC) Testing Market such as Abbott Laboratories, AccuBioTech, ACON Laboratories, bioLytical Laboratories, i-Health Lab and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 33 companies featured in this Global Over The Counter (OTC) Testing Market report include:

  • Abbott Laboratories
  • AccuBioTech
  • ACON Laboratories
  • bioLytical Laboratories
  • i-Health Lab
  • LabStyle Innovations
  • NOWDiagnostics Company
  • OraSure Technologies
  • Roche Diagnostics
  • SD Biosensor
  • Sinocare

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Global Economic Update
  • Over The Counter (OTC) Testing - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Growing Demand for Home-Based Health Monitoring Drives OTC Testing Market
  • Increasing Awareness About Preventive Healthcare Sets the Stage for OTC Testing Adoption
  • Rising Adoption of Self-Testing Kits for Chronic Disease Management
  • Increasing Use of OTC Testing in Monitoring Infectious Diseases Propels Demand
  • Demand for Rapid and Accurate Results Spurs OTC Testing Solutions
  • OTC Testing as a Key Solution for Reducing Healthcare Costs
  • Use in Detecting Lifestyle Disorders Expands OTC Testing Adoption
  • Rising Demand for Genetic Testing Kits Sets the Stage for Market Growth
  • Increasing Use of OTC Testing in Monitoring Diabetes and Heart Conditions
  • Increasing Focus on Female Health Solutions Expands OTC Testing Opportunities
  • OTC Testing for Allergies and Food Intolerances Generates Demand
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 2: World Historic Review for Over The Counter (OTC) Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 3: World 16-Year Perspective for Over The Counter (OTC) Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Glucose Monitoring Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 5: World Historic Review for Glucose Monitoring Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 6: World 16-Year Perspective for Glucose Monitoring Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Pregnancy & Fertility Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 8: World Historic Review for Pregnancy & Fertility Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 9: World 16-Year Perspective for Pregnancy & Fertility Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Infectious Disease Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 11: World Historic Review for Infectious Disease Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 12: World 16-Year Perspective for Infectious Disease Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 13: World Recent Past, Current & Future Analysis for Coagulation Monitoring Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 14: World Historic Review for Coagulation Monitoring Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 15: World 16-Year Perspective for Coagulation Monitoring Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 16: World Recent Past, Current & Future Analysis for Urinalysis Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 17: World Historic Review for Urinalysis Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 18: World 16-Year Perspective for Urinalysis Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 19: World Recent Past, Current & Future Analysis for Cholesterol Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 20: World Historic Review for Cholesterol Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 21: World 16-Year Perspective for Cholesterol Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 22: World Recent Past, Current & Future Analysis for Drugs-of-Abuse Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 23: World Historic Review for Drugs-of-Abuse Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 24: World 16-Year Perspective for Drugs-of-Abuse Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 25: World Recent Past, Current & Future Analysis for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 26: World Historic Review for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 27: World 16-Year Perspective for Other Test Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 28: World Recent Past, Current & Future Analysis for Immunoassays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 29: World Historic Review for Immunoassays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 30: World 16-Year Perspective for Immunoassays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 31: World Recent Past, Current & Future Analysis for Dipsticks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 32: World Historic Review for Dipsticks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 33: World 16-Year Perspective for Dipsticks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 34: World Recent Past, Current & Future Analysis for Lateral Flow Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 35: World Historic Review for Lateral Flow Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 36: World 16-Year Perspective for Lateral Flow Assays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 37: World Over The Counter (OTC) Testing Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
  • Over The Counter (OTC) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
CANADA
JAPAN
  • Over The Counter (OTC) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
CHINA
  • Over The Counter (OTC) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
EUROPE
  • Over The Counter (OTC) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
FRANCE
  • Over The Counter (OTC) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
GERMANY
  • Over The Counter (OTC) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
ITALY
UNITED KINGDOM
  • Over The Counter (OTC) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
REST OF EUROPE
ASIA-PACIFIC
  • Over The Counter (OTC) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
REST OF WORLDIV. COMPETITION

Companies Mentioned

  • Abbott Laboratories
  • AccuBioTech
  • ACON Laboratories
  • bioLytical Laboratories
  • i-Health Lab
  • LabStyle Innovations
  • NOWDiagnostics Company
  • OraSure Technologies
  • Roche Diagnostics
  • SD Biosensor
  • Sinocare

Table Information